FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2214278004> ?p ?o ?g. }

• W2214278004 endingPage "1050" @default.
• W2214278004 startingPage "1046" @default.
• W2214278004 abstract "Dolutegravir is a powerful, well-tolerated integrase inhibitor with a high genetic barrier to resistance and may thus constitute the backbone of lightened regimens.This was a monocentric, retrospective study. HIV-1-infected patients receiving dolutegravir as monotherapy (mDGV) or dual therapy (dDGV) were systematically identified. The primary outcome was the proportion of patients who maintained undetectable (<50 copies/mL) plasma HIV RNA [plasma viral load (PVL)].We identified 21 patients on mDGV (50 mg/day) and 31 on dDGV (50 or 100 mg/day, with atazanavir ± ritonavir, n = 12; rilpivirine, n = 11; maraviroc, n = 3; lamivudine, n = 3; darunavir/ritonavir, n = 1; or abacavir, n = 1). All of the patients were treatment experienced and 48% had experienced at least one virological failure. The baseline characteristics were as follows (for the mDGV/dDGV patients, respectively): 5%/29% had a history of AIDS; the median (IQR) highest PVL was 4.5 (4.3-5.5)/5.3 (4.7-5.6) log copies/mL; the median (IQR) nadir CD4+ count was 310 (280-468)/199 (134-281) cells/mm(3); 100% had undetectable PVL before the mDGV for a median (IQR) duration of 5.9 (3.5-9.9) years/81% had undetectable PVL before the dDGV for a median (IQR) duration of 3.7 (1.4-8.3) years; and the median (IQR) HIV DNA level was 2.7 (2.1-3.1)/2.9 (2.7-3) log copies/10(6) PBMCs. At the last follow-up visit, 100% and 97% of patients showed undetectable PVL following mDGV and dDGV, respectively [median (IQR) follow-up of 32 (29-45) and 50 (30-74) weeks, respectively].In our experience, dolutegravir-based lightened regimens provided a high proportion of viral suppression, even in highly treatment-experienced patients." @default.
• W2214278004 created "2016-06-24" @default.
• W2214278004 creator A5003679229 @default.
• W2214278004 creator A5027476765 @default.
• W2214278004 creator A5038475407 @default.
• W2214278004 creator A5043706594 @default.
• W2214278004 creator A5045135908 @default.
• W2214278004 creator A5055751945 @default.
• W2214278004 creator A5077818599 @default.
• W2214278004 creator A5078260023 @default.
• W2214278004 date "2015-12-27" @default.
• W2214278004 modified "2023-10-14" @default.
• W2214278004 title "Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients" @default.
• W2214278004 cites W1544659534 @default.
• W2214278004 cites W1990069515 @default.
• W2214278004 cites W2054025695 @default.
• W2214278004 cites W2068866500 @default.
• W2214278004 cites W2075002394 @default.
• W2214278004 cites W2094303174 @default.
• W2214278004 cites W2094811879 @default.
• W2214278004 cites W2108676219 @default.
• W2214278004 cites W2111865111 @default.
• W2214278004 cites W2133117185 @default.
• W2214278004 cites W2148750104 @default.
• W2214278004 cites W2158298030 @default.
• W2214278004 cites W2327688216 @default.
• W2214278004 cites W4240243247 @default.
• W2214278004 doi "https://doi.org/10.1093/jac/dkv430" @default.
• W2214278004 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4790618" @default.
• W2214278004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26712907" @default.
• W2214278004 hasPublicationYear "2015" @default.
• W2214278004 type Work @default.
• W2214278004 sameAs 2214278004 @default.
• W2214278004 citedByCount "59" @default.
• W2214278004 countsByYear W22142780042016 @default.
• W2214278004 countsByYear W22142780042017 @default.
• W2214278004 countsByYear W22142780042018 @default.
• W2214278004 countsByYear W22142780042019 @default.
• W2214278004 countsByYear W22142780042020 @default.
• W2214278004 countsByYear W22142780042022 @default.
• W2214278004 countsByYear W22142780042023 @default.
• W2214278004 crossrefType "journal-article" @default.
• W2214278004 hasAuthorship W2214278004A5003679229 @default.
• W2214278004 hasAuthorship W2214278004A5027476765 @default.
• W2214278004 hasAuthorship W2214278004A5038475407 @default.
• W2214278004 hasAuthorship W2214278004A5043706594 @default.
• W2214278004 hasAuthorship W2214278004A5045135908 @default.
• W2214278004 hasAuthorship W2214278004A5055751945 @default.
• W2214278004 hasAuthorship W2214278004A5077818599 @default.
• W2214278004 hasAuthorship W2214278004A5078260023 @default.
• W2214278004 hasBestOaLocation W22142780041 @default.
• W2214278004 hasConcept C126322002 @default.
• W2214278004 hasConcept C142462285 @default.
• W2214278004 hasConcept C147483822 @default.
• W2214278004 hasConcept C159047783 @default.
• W2214278004 hasConcept C195616568 @default.
• W2214278004 hasConcept C203014093 @default.
• W2214278004 hasConcept C2522874641 @default.
• W2214278004 hasConcept C2776258796 @default.
• W2214278004 hasConcept C2777302000 @default.
• W2214278004 hasConcept C2777869810 @default.
• W2214278004 hasConcept C2778037500 @default.
• W2214278004 hasConcept C2778414717 @default.
• W2214278004 hasConcept C2778723075 @default.
• W2214278004 hasConcept C2778899366 @default.
• W2214278004 hasConcept C2779182219 @default.
• W2214278004 hasConcept C2779298103 @default.
• W2214278004 hasConcept C2779465607 @default.
• W2214278004 hasConcept C2779502633 @default.
• W2214278004 hasConcept C2780404665 @default.
• W2214278004 hasConcept C2780593183 @default.
• W2214278004 hasConcept C2781413609 @default.
• W2214278004 hasConcept C2993143319 @default.
• W2214278004 hasConcept C3013748606 @default.
• W2214278004 hasConcept C71924100 @default.
• W2214278004 hasConcept C90924648 @default.
• W2214278004 hasConceptScore W2214278004C126322002 @default.
• W2214278004 hasConceptScore W2214278004C142462285 @default.
• W2214278004 hasConceptScore W2214278004C147483822 @default.
• W2214278004 hasConceptScore W2214278004C159047783 @default.
• W2214278004 hasConceptScore W2214278004C195616568 @default.
• W2214278004 hasConceptScore W2214278004C203014093 @default.
• W2214278004 hasConceptScore W2214278004C2522874641 @default.
• W2214278004 hasConceptScore W2214278004C2776258796 @default.
• W2214278004 hasConceptScore W2214278004C2777302000 @default.
• W2214278004 hasConceptScore W2214278004C2777869810 @default.
• W2214278004 hasConceptScore W2214278004C2778037500 @default.
• W2214278004 hasConceptScore W2214278004C2778414717 @default.
• W2214278004 hasConceptScore W2214278004C2778723075 @default.
• W2214278004 hasConceptScore W2214278004C2778899366 @default.
• W2214278004 hasConceptScore W2214278004C2779182219 @default.
• W2214278004 hasConceptScore W2214278004C2779298103 @default.
• W2214278004 hasConceptScore W2214278004C2779465607 @default.
• W2214278004 hasConceptScore W2214278004C2779502633 @default.
• W2214278004 hasConceptScore W2214278004C2780404665 @default.
• W2214278004 hasConceptScore W2214278004C2780593183 @default.
• W2214278004 hasConceptScore W2214278004C2781413609 @default.
• W2214278004 hasConceptScore W2214278004C2993143319 @default.

• next